Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB

The current study investigated the role of poly(ADP-ribose) polymerase (PARP) in the development of diabetic retinopathy. Activity of PARP was increased in whole retina and in endothelial cells and pericytes of diabetic rats. Administration of PJ-34 (a potent PARP inhibitor) for 9 months to diabetic rats significantly inhibited the diabetes-induced death of retinal microvascular cells and the development of early lesions of diabetic retinopathy, including acellular capillaries and pericyte ghosts. To further investigate how PARP activation leads to cell death in diabetes, we investigated the possibility that PARP acts as a coactivator of nuclear factor-κB (NF-κB) in the retinal cells. In bovine retinal endothelial cells (BRECs), PARP interacted directly with both subunits of NF-κB (p50 and p65). More PARP was complexed to the p50 subunit in elevated glucose concentration (25 mmol/l) than at 5 mmol/l glucose. PJ-34 blocked the hyperglycemia-induced increase in NF-κB activation in BRECs. PJ-34 also inhibited diabetes-induced increase expression of intercellular adhesion molecule-1, a product of NF-κB–dependent transcription in retina, and subsequent leukostasis. Inhibition of PARP or NF-κB inhibited the hyperglycemia (25 mmol/l glucose)-induced cell death in retinal endothelial cells. Thus, PARP activation plays an important role in the diabetes-induced death of retinal capillary cells, at least in part via its regulation of NF-κB.

[1]  Bernd Kirchhof,et al.  Nonsteroidal anti‐inflammatory drugs prevent early diabetic retinopathy via TNF‐α suppression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Lorenzi,et al.  Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.

[3]  A. Adamis,et al.  Is diabetic retinopathy an inflammatory disease? , 2002, The British journal of ophthalmology.

[4]  M. Hottiger,et al.  The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders , 2002, Cellular and Molecular Life Sciences CMLS.

[5]  M. Davis,et al.  Patterns of ischemia in diabetic retinopathy. , 1976, Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology.

[6]  Mark P. Mattson,et al.  NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .

[7]  C. Gerhardinger,et al.  Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. , 2002, Diabetes.

[8]  M. O’connor,et al.  Poly(ADP-Ribose) Polymerase-1 Regulates Activation of Activator Protein-1 in Murine Fibroblasts1 , 2003, The Journal of Immunology.

[9]  W. Chang,et al.  The Sequence-specific DNA Binding of NF-κB Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1* , 2001, The Journal of Biological Chemistry.

[10]  F. Gallyas,et al.  Novel phenanthridinone inhibitors of poly(adenosine 5′-diphosphate-ribose) synthetase: Potent cytoprotective and antishock agents* , 2002, Critical care medicine.

[11]  Changlian Zhu,et al.  Involvement of apoptosis‐inducing factor in neuronal death after hypoxia‐ischemia in the neonatal rat brain , 2003, Journal of neurochemistry.

[12]  M. Gillies,et al.  The retina: oxidative stress and diabetes , 2003, Redox report : communications in free radical research.

[13]  T. Kern,et al.  Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin. , 2001, Diabetes.

[14]  F. Ismail-Beigi,et al.  Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. , 2000, Diabetes.

[15]  T. Okamoto,et al.  Evidence for regulation of NF-kappaB by poly(ADP-ribose) polymerase. , 2000, The Biochemical journal.

[16]  S. Snyder,et al.  Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[18]  S. Chakrabarti,et al.  Diabetes-induced Activation of Nuclear Transcriptional Factor in the Retina, and its Inhibition by Antioxidants , 2003, Free radical research.

[19]  Z. Yang,et al.  Effect of genetic disruption of poly (ADP-ribose) synthetase on delayed production of inflammatory mediators and delayed necrosis during myocardial ischemia-reperfusion injury. , 2000, Shock.

[20]  Ulrich Schraermeyer,et al.  A central role for inflammation in the pathogenesis of diabetic retinopathy , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  T. Gilmore,et al.  Control of apoptosis by Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[22]  A. Baldwin Series Introduction: The transcription factor NF-κB and human disease , 2001 .

[23]  B Kirchhof,et al.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina. , 2001, The American journal of pathology.

[24]  É. Szabó,et al.  The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. , 2002, Diabetes.

[25]  B. Aronow,et al.  Absence of Poly(ADP-ribose) Polymerase-1 Alters Nuclear Factor-κB Activation and Gene Expression of Apoptosis Regulators after Reperfusion Injury , 2003, Molecular medicine.

[26]  R. Alvarez-González,et al.  Regulation of p53 Sequence-specific DNA-binding by Covalent Poly(ADP-ribosyl)ation* , 2001, The Journal of Biological Chemistry.

[27]  C. Szabó,et al.  DNA damage induced by peroxynitrite: subsequent biological effects. , 1997, Nitric oxide : biology and chemistry.

[28]  S. Mohr,et al.  Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. , 2002, Diabetes.

[29]  M. Mattson,et al.  NF-kappaB in neuronal plasticity and neurodegenerative disorders. , 2001, The Journal of clinical investigation.

[30]  C. Szabó,et al.  Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant-induced cell death. , 1998, Journal of immunology.

[31]  C. Szabó,et al.  The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors , 2002, Pharmacological Reviews.

[32]  Timothy S Kern,et al.  Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.

[33]  N. Perkins The Rel/NF-κB family: friend and foe , 2000 .

[34]  V. Dawson,et al.  Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. , 1998, Trends in pharmacological sciences.

[35]  K. Miyarnoto Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[36]  Mark A. Smith,et al.  Diabetes‐induced nitrative stress in the retina, and correction by aminoguanidine , 2002, Journal of neurochemistry.

[37]  J. Węsierska‐Gądek,et al.  Poly(ADP-ribose) polymerase-1 regulates the stability of the wild-type p53 protein. , 2001, Cellular & molecular biology letters.

[38]  Fei Li,et al.  Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. , 2004, Diabetes.

[39]  C. Hirschberg Golgi nucleotide sugar transport and leukocyte adhesion deficiency II , 2001 .

[40]  S. Snyder,et al.  Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia , 1999, Brain Research.

[41]  T. Kern,et al.  Retinal glutamate in diabetes and effect of antioxidants , 2001, Neurochemistry International.

[42]  M. Covic,et al.  The Enzymatic and DNA Binding Activity of PARP-1 Are Not Required for NF-κB Coactivator Function* , 2001, The Journal of Biological Chemistry.

[43]  T. Dawson,et al.  Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor , 2002, Science.

[44]  M. Kameoka,et al.  Expression of histone acetyltransferases was down-regulated in poly(ADP-ribose) polymerase-1-deficient murine cells. , 2003, Biochemical and biophysical research communications.

[45]  N. Perkins The Rel/NF-kappa B family: friend and foe. , 2000, Trends in biochemical sciences.

[46]  A. Baldwin Series introduction: the transcription factor NF-kappaB and human disease. , 2001, The Journal of clinical investigation.

[47]  L. Rossetti,et al.  Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. , 2003, The Journal of clinical investigation.

[48]  M. Moskowitz,et al.  Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders , 2003, Journal of neurochemistry.

[49]  A. Spradling,et al.  Chromatin Loosening by Poly(ADP)-Ribose Polymerase (PARP) at Drosophila Puff Loci , 2003, Science.

[50]  M. Hottiger,et al.  Transcriptional Coactivation of Nuclear Factor-κB-dependent Gene Expression by p300 Is Regulated by Poly(ADP)-ribose Polymerase-1* , 2003, Journal of Biological Chemistry.

[51]  Y. Ogura,et al.  Platelets accumulate in the diabetic retinal vasculature following endothelial death and suppress blood-retinal barrier breakdown. , 2003, The American journal of pathology.

[52]  R. Andriantsitohaina,et al.  Resistance to endotoxic shock as a consequence of defective NF‐κB activation in poly (ADP‐ribose) polymerase‐1 deficient mice , 1999, The EMBO journal.

[53]  G. Romeo,et al.  Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. , 2000, Investigative ophthalmology & visual science.

[54]  C. Le Page,et al.  Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. , 1998, Biochemical and biophysical research communications.